Background and Aim: Earlier assessment of Pueraria tuberosa tubers has shown anti-diabetic effects through incretin mimetic action and DPP-IV inhibition. The aim of this work was to further explore the protective role of aqueous extract of Pueraria tuberosa against streptozotocin (STZ)-induced pancreatic stress in rats.
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Abbreviations: STZ (Streptozotocon), PTY 2 (Pueraria tuberosa water extract), SOD (Superoxide dismutase), NFkB (nuclear factor kappalight-chain-enhancer of activated B cells), PKC ε (Protein kinase C ε ), TNF α (Tumour necrosis factor α ), MMP 9 (Matrix metalloproteinases 9), HIF 1α ( Hypoxia inducible factor α ), VEGF (Vascular endothelial growth factor).
1. PTY 2 act as a protective herbal drug against STZ induced islet stress. 2. PTY 2 upregulates protective and downregulates harmful markers. 3 . This study composed of four pathway through which PTY 2 acts on pancreas.
Background
In addition, mortality and morbidity due to diabetes mellitus (DM) are also rising rapidly worldwide [1, 2] . Type 2 DM (T2DM) increases the risk of acute pancreatitis by 1.5-3 folds, and the use of anti-diabetic drugs decreases this excess risk [2] . On the other hand, pancreatitis is one of the known risk factors for the onset of DM [3] [4] [5] . Additionally, the onset of DM can be a symptom of pancreatic cancer as the latter is more common among newly diagnosed cases of T2DM. Furthermore, long-standing DM can increase the risk of occurrence of pancreatic cancer [6] [7] [8] [9] . Apart from the known etiological factors, pathological changes due to environmental factors or other unknown reasons can alter the gene expression and lead to diseases like DM, pancreatic cancer, acute or chronic pancreatitis [10, 11] . Both in-vivo and in-vitro models are being developed to understand the mechanisms underlying the profile change in gene expression. Many synthetic drugs and herbal formulations have been developed for the prevention and treatment of DM.
The aqueous extract of one of the herbal products, Pueraria tuberosa tubers (PTY-2), is being evaluated for its protective role in STZ induced islet stress. In our earlier studies, we had evaluated the role of PTY-2 in animal models of streptozotocin (STZ)-induced DM and in normoglycemic rats [11] [12] [13] . PTY-2 has also been studied for its anti-inflammatory, antioxidant, nephroprotective, anti-hypertensive, anxiolytic and hypoglycemic properties [12, [14] [15] [16] [17] [18] [19] [20] . The analysis of actions of PTY-2 shows that there must be interconnecting signaling pathways between anti-inflammatory, antioxidants and anti-diabetic genes for the effect of PTY-2. Taking our research forwards, we have attempted to study the signaling pathways to understand the role of antioxidant, antiapoptotic, anti-hypoxic and anti-inflammatory properties in providing a protective role in pancreatic damage.
Various markers like Nephrin, Superoxide dismutase (SOD), Hypoxia Inducible Factor-1α (HIF-1α), Tumor Necrosis Factor-α (TNF-α), Matrix metalloproteinase 9 (MMP-9), Caspase-3, Nuclear factor kappa B (NF-kB), Vascular Endothelial Growth Factor (VEGF), Protein kinase C epsilon (PKC ε ), and Interleukin-6 (IL-6) have been used to study the effect of drugs or herbal products on DM. Earlier studies have demonstrated increased levels of VEGF, TNF-α, MMP-9, IL-6, NF-kB, PKC ε , and HIF 1α in inflammatory conditions, vascular lesions and DM [21] [22] [23] [24] [25] . Excess generation of reactive oxygen species (ROS) and oxidative stress is one of the common etiological pathways in the development and progression of DM [26, 27] . Nephrin, a member of immunoglobulin super family, is a surface receptor that is specifically expressed in kidney, brain and pancreas [28] . In the beta cells of islet of Langerhans of pancreas, nephrin plays an important role in beta cell survival signaling through the association with PI3-kinase in mouse islet β -cells and mouse pancreatic beta-cell line (βTC-6 cells) [29] . VEGF is a vital regulator of vascularization of islet cells, and the islet vascular system is critical for a normal section of insulin [30, 31] . Genetic studies have shown that normal VEGF and vascularization are important for adult islet cell function and β cell mass [25] . The β cell-specific overexpression of VEGF causes rapid hypervascularization and hyperinnervation of the islet, leading to increased production of extracellular matrix components (ECM) [32] . Hence, we can say that increased amount of VEGF is responsible for defective angiogenesis. MMPs are a large family of endopeptidases, and these are produced by stromal and inflammatory cells. Pancreatic MMPs (especially MMP-9) induce inflammation, and serum MMP-9 levels are an assessment marker of severity of pancreatitis [33] . MMP-9 is usually involved in degradation and remodeling of ECM components and cellular migration [22, 34, 35] . NF-kB, a nuclear transcription factor, regulates the transcription of various genes involved in inflammation mediation [36] . The activation of NF-kB is an early pathological event in the development of insulin resistance [37] . TNF-α, an inflammatory marker, is rapidly produced intracellularly with the activation of NF-kB and is known to have effects on insulin transduction and obesity [21, 38] .The PKC ε belongs to the superfamily of isoforms of protein kinases. PKC ε is involved in the development of insulin resistance, and its inhibition is associated with the improvement in glucose homeostasis in animal models [39] . PKC ε has a strong presence in islet cells, acinar cells, and ductal epithelium [40] . Similarly, both, IL-6 and HIF-1α are also known to play a pro-inflammatory role in the mediation of acute pancreatitis and pancreatic cancer [23, 24] . Hypoxia is an important cause of beta-cell loss and is measured by an increase in HIF-1α expression [41] . Various gene knockout experiments have shown that caspase-3 is involved in beta cell apoptosis and that Casp -/are protected from the development of DM [42] .
water extract rather than on its individual components. Because Pueraria tuberosa contains many steroids, triterpenoid, glycosides, carbohydrates, alkaloids, flavanoid, tannin, protein and amino acids,e.g., daidzin, puerarin, puerarone, genistein, puetuberosanol, tuberostan, tuberosin, and puerarin 4',6'-diacetate as the main constituents [12, 14, 43] . We planned to study the multitargeted protective effect of PTY-2 on the pancreatic damage among rats with STZ-induced stress.
Research design and methods

Materials
The 
Sample preparation
Pueraria tuberosa was purchased from Ayurvedic Pharmacy, Banaras Hindu University. Its authenticity has already been ascertained in our previous research [44] . We extracted 30 g powder with eight volumes of distilled water. When the volume was reduced to ¼th, it was filtered with cloth. The total yield of Pueraria tuberosa water extract (PTY-2) obtained by this process was 30%.
Study Design
The protocol was approved by the Institute Ethical Committee (Dean/2015/CAEC/1266), Institute of Medical Sciences, Banaras Hindu University. After overnight fasting, Charles foster male rats of the same age group with body weight in the range of 120-130 grams were injected STZ (65 mg/kg body weight). STZ was prepared in chilled and fresh citrate buffer of pH 4.5. The blood glucose levels were checked using strips (Dr.Morepen) on the 5 th day. Rats with blood glucose levels > 200 mg/dL were placed under diabetic group. In order to induce severe diabetes, we left the rats (three rats per cage) for 55 days. On the 61 st day, we divided the rats into three groups (n=6): Group-1 (STZ untreated rats, i.e., age-matched normal control), Group-2 (diabetic control), and Group-3 (PTY-2 at 50 mg/100 g bw treatment for 10 days to diabetic rats). The rats were then sacrificed after 10 days of treatment. The pancreas was isolated and rinsed with PBS. Then, these were cut into two parts; one for histology (preserved in 10% formaldehyde) and the other was first crushed in liquid nitrogen and then stored in -80 o C freezer for molecular study.
Reverse transcription-polymerase chain reaction (RT-PCR)
RNA was extracted using Trizol reagent from about 50 mg of pancreatic tissue with a homogenizer. Then 5 µg of total RNA was reverse- were performed in triplicates (Table 1) .
Western blot analysis
Washed pancreatic tissue (10% ice-cold PBS) was homogenized with chilled lysis buffer (50 mMTris pH 7.6, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% triton, 0.1% SDS, 1 mM sodium orthovanadate, protease inhibitor cocktail and 1 mM PMSF). The homogenate was then centrifuged at 12,000 rpm at 4 o C for 30 min. The protein estimation was done by Bradford method according to which 40 μ g proteins with loading dye were separated in the polyacrylamide gel. The gel was then electro-transferred to PVDF membranes in transfer buffer (10X Tris- 
Statistical analysis
One-way ANOVA test followed by post hoc analysis with Dunnett's test was done for each experiment. All results were expressed as means ± SD. Statistical significance was taken at p ≤ 0.05.
Results
PTY2 response to pancreatic inflammation mRNA EXPRESSIONS
As compared to normal rats, the STZ-treated diabetic group showed a significant increase in TNF α in pancreatic tissue, whereas the PTY-2 treatment significantly decreased the TNF α expression as compared to diabetic control and increase as compared to normal. The MMP-9
expression also increased significantly in diabetic control as compared to normal rats, and there was a significant decrease after 10 days of PTY 2 treatment. On the contrary, both SOD and Nephrin expression decreased significantly in diabetic control rats as compared to normal. However, the PTY 2 treated group showed a significant increase in SOD expression as compared to diabetic control and a significant decrease as compared to normal. The Nephrin expression in PTY 2 treated rats increased significantly as compared to both normal and diabetic control ( Fig. 1 (a) and
These results clearly indicate that in chronic diabetes, there is significant increase in free radicals/ stress accompanied by increase in pancreatic inflammation. Treatment with PTY 2 significantly reversed all these changes. Thus, any severe complications of severe diabetes like pancreatitis could be prevented by using PTY 2 as medicinal supplement. 1 1 
PROTEIN EXPRESSIONS
Western blot
For further validation, the protein expressions responsible for the induction of oxidative stress, hypoxia, apoptosis and inflammation of pancreatic tissues were estimated. The expressions of NF-kB, PKC ε , HIF-1α, VEGF and IL-6 were significantly increased in diabetic control as compared to normal rats. However, PTY 2 treatment significantly decreased all these expressions ( Fig. 2 (a) and (b) ).
Immunohistochemistry
Discussion
The results of our study showed that, compared to the diabetic control group, the PTY-2 group had a favorable change in the expressions of biomarkers as assessed by RT-PCR, Western blot and IHC techniques. Analysis showed that STZ increased the expressions of MMP-9, TNFα , HIF-1α, VEGF, IL-6, PKC ε , NF-kB and Caspase-3 in diabetic control. But these expressions were significantly decreased by the treatment with PTY-2 for 10 days. Expression of SOD and Nephrin were significantly decreased among diabetic control rats, and these increased significantly after the administration of PTY-2. Both RT-PCR and western blot estimation showed a favorable change in expressions of the biomarkers for oxidative stress and inflammation.
Our earlier research had focused on the antidiabetic role of PTY-2 in STZ-induced diabetic model. In those studies, we found that PTY-2 has an effect on inflammation (Pandey et al., 2013), hyperglycemia and incretin pathways. Initially, the results showed that PTY-2 had hypoglycemic action because of inhibition of dipeptidyl peptidase-IV (DPP-IV) activity. In further research, we evaluated the effect on incretin receptor (GLP-1R and GIP-R), and insulin. The results showed that PTY-2 treatment led to a significantly higher increase in GLP-1 and GIP levels and a significant decrease in glucose concentrations after PTY-2 treatment (50 mg/100 g body weight) for 10 days. In the second study of chronic DM induced with STZ among rats,, there was also a significant decrease in DPP-IV activity and an enhanced basal insulin concentration in PTY-2 treated diabetic rats. Additionally, there was an increase in the number of islet cells and a significant increase in protein expression of insulin and Bcl-2. According to in silico study in our lab, Puerarone and Robinin were the two most effective phytochemicals for DPP-IV inhibition, and tuberostan and puererone identified as the active component against GLP-1 and GIP receptors. Moreover, an in-vivo experiment showed that anti-inflammatory property of Pueraria tuberosa might be because of the scavenging of free radicals by increase in activity of SOD, and decrease in C-reactive protein levels [15] .
Moving in the same direction of evaluation of the role of PTY-2 in DM, we studied the effect of PTY-2 on the markers of oxidative stress, hypoxia, apoptosis and inflammation, which are known to play a significant role in the development and progression of pancreatitis and DM. We evaluated the change in expressions of mediators of inflammation and oxidative stress after STZ treatment followed by administration of PTY-2 for 10 days. The immunohistochemical, PCR and western blot analysis of our study showed an increase in the expression of MMP-9, TNF α HIF-1α,VEGF, IL-6, PKC ε , NF-kB and Caspase-3 as well as reduced expression of Nephrin and SOD after 60 days of STZ treatment in group 2 (Figures 1,2, 3, 4 , 5, 6).
To understand and assimilate the results, the pathological changes in DM along with the proposed mechanism of action of PTY-2 according to our study have been diagrammatically shown in Graphical abstract. DM is a manifestation of abnormal metabolism and transport of glucose, and may be associated with a decrease in insulin secretion and presence of insulin resistance. Further on, this leads to hyperglycemia and an increase in the release of free fatty acids (FFAs) [45] . All these inter-related steps decrease β -cell function and number, increase oxidative stress, induce apoptosis and endoplasmic reticulum stress, and increase the release of inflammatory cytokines [45] . FFAs are known to induce the release of various interleukins, including IL-6, which further increase the release of free radicals and activate caspases. As shown in graphical abstract, NFκ B, PKCε, TNFα, and IL-6 are mediators of inflammation, and the administration of PTY-2 in our study was associated with a decrease in the expression of all these mediators. With the progression of diabetes, the balance between the pro-inflammatory and anti-inflammatory or protective mediators is disturbed [45] . The increase in oxidative stress, measured by a decrease in SOD activity and an increase in ROS, was also decreased by PTY-2 administration. Other mediators of oxidative stress, i.e., MMP-9 and VEGF, were also decreased. Hypoxia, which is measured with HIF 1α, is also an inducible factor of DM and was decreased by PTY-2 administration. Apoptosis, one of the critical pathological changes, is mediated by an increase in activity of caspases [42] . PTY-2 led to a decrease in caspase-3 expression. Taking into consideration of our earlier evidence, it can be proposed that PTY-2 acts as a DPP-IV inhibitor, potentiates GLP-1 and GIP [13] mediated responses, and decreases inflammation, oxidative stress, apoptosis and hypoxia. GLP-1 agonists showed an inhibition of pro-inflammatory mediators in DM and other inflammatory conditions as well, in addition to their glucose-lowering potential [46, 47] .
MMP-9, one of the markers estimated in our study, deteriorates the inflammatory condition as it causes vascular injury, increases migration and cellular invasion by inflammatory cells [22, 33] . Both animal and human studies have shown an increase in MMP-9 expression in pancreatitis [48, 49] . MMP-9 acts as a diabetogenic factor by increasing proteolytic cleavage of insulin and generation of immunodominant insulin peptides [48, 49] . Similar to our results, earlier studies have also shown an induction/increase of MMP-9 activity in STZ-induced models of DM [22] . It is assumed that hyperglycemia induced oxidative stress induces the expression of MMP-9 in pancreas, and this can be counterbalanced with GLP-1 agonists [22, 50] . However, MMP-9 along with other paracrine factors is required for normal islet matrix turnover in the pancreatic islets [51] .
IL-6, another inflammatory mediator, is also known to perform both inflammatory and protective roles [45] . In type 1 DM, IL-6 maintains the balance of cytokines; however, it is related with both initiation and progression of insulin resistance in T2DM [45] . However, PKC ε inhibition/deletion is associated with an improvement in glucose homeostasis [39] . In a previous study, when the Psammomys (sand rats) were fed with high energy diet, they developed insulin resistance mimicking T2DM. Treatment with PKC ε abrogated peptides and prevented insulin resistance, hyperinsulinemia and pancreatic beta cell loss. It shows that the enhanced expression of PKC ε in T2DM is associated with beta cell loss [52] . In another study with culture of lipid-treated islets isolated from PKCε knockout (PKCεKO) mice, there occurred amplification of GSIS (glucose-stimulated-insulin-secretion), reinforcing the benefit of inhibition of PKCε [39] . Our results also showed a significant increase in the diabetic group, followed by a significant decrease in the PTY-2 group.
Pro-inflammatory and pro-apoptotic cytokines like IL-1β are involved in the development and progression of insulin resistance via the decrease in the number and functioning of β cells. NF-κB is a transcription factor for mediating the cellular responses of inflammatory cytokines like IL-1β. The activation of NF-κB leads to a permanent decrease in the expression of proteins of β cells [45] . NF-kB pathways control cellular proliferation, inflammation, and immune responses through signal transduction [21, 53] . The activity of NF-kB is increased in acute pancreatitis, and the longer duration of increased activity is associated with chronic disease [54] [55] [56] [57] . Sitagliptin, a DPP-IV inhibitor used among T2DM patients, has shown anti-inflammatory action through the inhibition of NF-κB, inflammatory cytokines and cell apoptosis [58] . Mice deficient in NF-κB have shown to be resistant to STZ-induced diabetes [59] .
In addition to the inter-relationship among MMP-9, IL-6, ROS, and NF-kB pathway, TNF-α is also a part of this pathological process [60] . The effects of TNF-α are mediated through the activation of NF-kB pathway. A decrease in IL-1action and an increase in the expression of TNF-α gene can increase the risk of onset and progression of the risk of DM [21] . Although the administration of TNF-α to animals is associated with insulin resistance and the regulation of TNF-α levels can improve insulin sensitivity, the status of TNF-α as a drug target for DM is still being evaluated. This might be possible with more understanding of the inter-relationships of the mediators in the pathogenesis of DM [61] .
Hyperglycemia also leads to the destabilization of HIF-1α, which is responsible for the regulation of the cellular responses to hypoxia. [62, 63] .
Hypoxia is an important cause of apoptosis and beta cell loss, and HIF-1α is an important indicator of beta cell loss [64] . It is known that GLP-1R agonists (Extendin-4) improve islets survival through the activation of transcription factor, cAMP response element binding protein (CREB).
A combination of CREB and Extendin-4 exerted enhanced anti-apoptotic action in cultured islets against hypoxia and cytokines. In an early phase, HIF-1α comes as a metabolic adaptation, but its prolonged activation causes the expression of proapoptotic genes with apoptosis showing both its upregulation and downregulation accordingly [64] . Increased levels of caspases, along with the hypoxic state, are involved in beta cell apoptosis [65] . Caspase-3, an important effector of the apoptotic pathways of DM, was also evaluated in our study [42] . A study among Caspase-3 knockout (Casp -/-) mice has shown that these mice were protected from the development of DM with a low-dose administration of STZ, which, otherwise, causes selective β cell destruction and further triggers the immune reactions in islet cells [42] . Studies with GLP-1 analogs among the animal models, in-vitro cell lines and human islet cells have shown a reduction in apoptosis, which was associated with a significant downregulation of caspase-3 and up-regulation of bcl-2, and an increase in intracellular insulin content [47, 64, 66, 67] . In an earlier study, Puerarin, one of the components of PTY-2, decreased the expression of caspase-3 in osteoblasts of diabetic rats and improved the pathological changes in diabetic rats [68] .
HIF-1α is also a transcriptional activator of VEGF [69] . VEGF, a pro-angiogenic growth factor, helps in the vascularization of the pancreatic islets [31, 70] . Currently, anti-VEGF therapy is approved for use in diabetic retinopathy [71] . Additionally, the effect of GLP-1 and DPP-IV inhibition are being evaluated in diabetic ulcers and for cardiovascular protective role [69, 72] . Oxidative stress, measured by the presence of ROS, is also a promoter of angiogenesis [70] .
Hyperglycemia also impairs nephrin signaling by increasing its internalization and the up-regulation of PKC-α expression, thus, playing an interesting role against gradual pancreatic β -cell loss in T2DM [29] .
have become clearer over years, the currently available drugs should be re-evaluated for their effects on newer targets. Additionally, there is a need of newer agents which have action beyond the glucose-lowering potential. Various compounds have been studied for their role in the treatment of DM. A novel transcriptional inhibitor of TNF-α, MDL 201.449, has been found to reduce TNF-α mRNA levels dose dependently and prevent the development of hyperglycemia among mice following STZ injections [73] .
PTY-2 is a herbal medicine under evaluation for its role in DM. As mentioned earlier, PTY-2 has shown anti-diabetic action by inhibition of DPP-IV enzyme, by acting as incretin receptor agonist, and by decreasing β cell apoptosis. Further pre-clinical and clinical research can help in the utilization of PTY-2 as a treatment option in DM. PTY-2 can be a less costly treatment option as compared to the already available antidiabetic drugs. As PTY-2 extract is composed of many phytochemicals, it can be effective for multiple diseases. On the other hand, an evaluation of the limitations of the study shows that this study did not evaluate the role of individual phytochemicals in DM. Overall, further post-translational studies are required to completely understand the protective effect of PTY-2 on pancreas.
Conclusion
Administration of PTY-2 for 10 days decreased the expressions of various biomarkers of oxidative stress and inflammation such as MMP-9, SOD, NF-κB, VEGF, TNF-α, Caspase-3, IL-6, and HIF-1α among STZ-induced diabetic rats as compared to controls. In addition, our results GRAPHICAL ABSTRACT. Mechanism of action of PTY 2 against STZ induced islet stress. 
